2023 UNCF “A Mind Is…” Gala – New England

Clemmie Cash was born in Tyler, TX but lived in Fort Worth, TX during most of her early life through high school. She graduated from the University of Texas at Arlington in Sociology and began her life of work focused on community service and education at the East Dallas Community Center in Dallas, TX. Later, she taught sociology at Langston University in Langston, OK while pursuing graduate work at Oklahoma State University.

Following jobs in retail while living in Indiana, and at New England Nuclear (radioactive chemicals for research and medical diagnosis) after moving to the Boston area, she resigned from full-time work in for-profit companies to devote her time to philanthropic activities and to her family.

Among the organizations she served as President, Director or Trustee in the greater Boston area were the Wellesley A Better Chance Program, The Home for Little Wanderers, The Boston Computer Museum, The Women’s Executive Network, Mount Auburn Cemetery, and The Noble & Greenough School. She is currently serving as a Co-Chair for The Campaign for Mass General Hospital, and is a Founding Donor of the Smithsonian National Museum of African American History and Culture.

Clemmie enjoys playing tennis, golf, traveling and photography trips with groups that have taken her to many domestic and international locations including Iceland, India, Brazil, China, Argentina, Portugal, Cambodia/Laos, France, Italy, Portugal, Australia, Singapore, Brussels, Netherlands, Spain, Switzerland and Romania. However, the thing she enjoys most are her babysitting assignments with her two grandchildren.

Dr. Cash served on the Boards of fifteen Fortune 100 companies, including Walmart, Microsoft, Chubb, General Electric, Sprint, Scientific Atlanta, and State Street Corp. He has served as an investor and on the boards of over thirty early-stage enterprise software companies including Veracode, Phase Forward, and Carbon Relay. He is currently serving on the boards of Aura, WELL and The Boston Celtics while also serving as Chairman and CEO of Catalyst Partners Acquisition Corporation and the Catalyst Partners Foundation.

Among the many non-profit organizations he has served are Mass General Hospital, The Smithsonian National Museum of African American History and Culture, Mass Computer Software Council, The Gardner Museum, Babson College, Partners HealthCare, The National Association of Basketball Coaches Foundation, Harlem Children’s Zone, Newton-Wellesley Hospital and the Boston Museum of Science.

Under the umbrella of The Cash Catalyst LLC, Dr. Cash runs personal development programs for executives and board members of Global 500 organizations interested in the intersection of information technology and corporate strategy. He also currently serves as an advisor to General Catalyst Partners and Grain Management.

Dr. Cash graduated from Texas Christian University (TCU) with a B.S. in Mathematics, while being named an Academic All-American in basketball. Later he received a Master of Science in Computer Science from Purdue University’s Graduate School of Mathematical Sciences; and a Doctor of Philosophy in Management Information Systems (MIS) and Accounting from Purdue University’s Krannert Graduate School of Management.

Among his honors and awards: Fellow of the American Academy of Arts and Sciences; The Greenhill Award from HBS; Academic All-American Hall of Fame; Texas Sports Hall of Fame; Honorary Doctorate from Babson College; John McLendon Pioneer Award; John S. Day Award from Purdue’s Krannert School of Business; Phi Kappa Phi Honor Society; his retired jersey number is painted in the rafters of Schollmaier Arena at TCU where a statue was dedicated in November 2022; and in 2020 the Harvard Business School renamed one of its buildings the Cash House.

John B. Hynes, III is the CEO and Managing Partner of Boston Global Investors. Mr. Hynes’ roots in Boston run deep. He is a long-time resident of the Boston area, attended Harvard College (Class of 1980). His father, Jack was regarded as “the dean of Boston broadcasting” and his grandfather, John B. Hynes served as the City’s Mayor from 1949 — 1959 and has been referred to as “the architect of the New Boston”.

After graduating from Harvard, Mr. Hynes spent ten years as a commercial leasing and sales broker with the Codman Company and RM Bradley & Co. and ten years as the local Operating Partner for Lincoln Property Company. During that time, he participated in more than three hundred leasing and sales transactions in the Boston market totaling over six million square feet and developed three office projects totaling two million square feet with an aggregate value in excess of one billion dollars.

From 2000 to 2010, as President/CEO of Gale International, he oversaw the acquisition, planning and permitting of the $700 million One Lincoln Street project (State Street Financial Tower), the $35 billion, 100-acre master plan New Songdo City project in Incheon, South Korea. In 2010, Mr. Hynes split off from Gale, founded Boston Global Investors and turned his attention to the development of the $3.5 billion Seaport Square master plan project in Boston with Morgan Stanley. That joint venture funded and developed 10 of the 22 permitted projects, totaling 2.5 million square feet with a total value of $3 billion. In October 2015, Morgan Stanley and BGI sold the remaining 12 approved development sites, totaling 3 million FAR, for what was then a record land price of $125/FAR.

Today, Mr. Hynes is focused on the development of the $600 million, 550,000 + SF Lab/Office tower at 10 World Trade, and in collaboration with CIM, the $600 million, 650,000 SF mixed-use MotorMart site in Boston’s Back Bay.

Throughout his career, Mr. Hynes has remained committed to a number of charitable organizations within the Boston and Cape Cod communities and sits on the board of several non-profit and professional organizations. John is a graduate of Harvard College where he co-captained the 1980 hockey team. He is the proud parent of five children—one son and four daughters, two stepchildren and eleven grandchildren. He resides in South Boston, Massachusetts, Chatham, Massachusetts and Delray Beach, Florida.

Reshma Kewalramani, M.D., FASN, is the Chief Executive Officer and President at Vertex Pharmaceuticals. Dr. Kewalramani has dedicated her career to improving the lives of patients, including the last 15+ years through the development of new medicines. She joined Vertex in 2017 and was previously the Chief Medical Officer and Executive Vice President of Global Medicines Development and Medical Affairs. During that time, Vertex made remarkable progress to bring new medicines to more people with cystic fibrosis (CF) around the world, including the approval of SYMDEKO®/SYMKEVI® and the rapid approval of TRIKAFTA®/KAFTRIO® to potentially treat up to 90% of all people with CF. Under Dr. Kewalramani’s leadership as CEO, Vertex has expanded its leadership in CF and advanced several programs into the clinic, including APOL1-mediated kidney disease, sickle cell disease, beta thalassemia and type 1 diabetes.

Dr. Kewalramani is passionate about developing and supporting the next generation of scientists and giving back to her community. She is a member of the board of directors of the Biomedical Science Careers Program, an organization dedicated to supporting underrepresented students to pursue a career in STEM. She is also a member of the Boston University School of Medicine Dean’s Advisory Board, the Massachusetts General Hospital Board of Trustees, and the Ginkgo Bioworks board of directors. She is a Fellow of the American Society of Nephrology and was on the inaugural board of directors of the Kidney Health Initiative.

She is the recipient of the Harvard Medical School Excellence in Teaching Award. In 2019, Dr. Kewalramani received the TiE Boston Healthcare Leadership Award and was named one of Boston Business Journal’s Power 50. In 2020, Business Insider named her one of 10 people transforming health care, and she was included on the PharmaVOICE 100 list of the most inspiring and influential leaders in the life sciences and Boston Business Journal’s list of Women Who Mean Business. In 2021, Dr. Kewalramani received the Golden Door Award from the International Institute of New England and was named a New Englander of the Year by the New England Council. Under her leadership as CEO, Vertex was ranked #2 on The Commonwealth Institute’s Top Women-Led Businesses in Massachusetts in 2021

Dr. Kewalramani completed her internship and residency in internal medicine at the Massachusetts General Hospital and her fellowship in nephrology at the Massachusetts General Hospital and Brigham and Women’s Hospital combined program. She received her medical degree, with honors, from the seven-year medicine program at the Boston University School of Medicine and completed the General Management Program at Harvard Business School.